John R Fischer

Cost containment, accelerated time-to-market, recurring revenues and strong cash flows are driving PE interest in the CDMO market.

65 Equity Partners, Arlington Capital Partners and Vance Street Capital are among the PE firms targeting investments in the CDMO market.

Calex Partners, Goldman Sachs and Shore Capital are investing in autism care.

Some takeaways from an SS&C Intralinks report on how tariffs may affect deal activity in the second quarter of 2025; a conversation with with Michelle Mantine, partner at law firm Reed Smith, about how the FTC's decision to retain 2023 merger guidelines may affect healthcare investing; the demand for clinical research technologies.

'I think it's going to be easier to do deals in those sectors where there isn't much concentration or consolidation,' she says.

Archimed, Astorg, HIG and TSCP are among the PE firms investing in companies producing clinical research technologies.

Ossman helps lead the firm’s investment efforts across medical products and diagnostic services and is helping the firm to invest its fifth fund.

A 5-deal listicle that explores trends driving attraction to the packaging and storage segment; a look at an add-on deal by a portfolio company of Reynolda Equity Partners; some insights by Bain & Company on the 2025 private equity market in the Asia-Pacific.

1315 Capital, Aurora Capital and Platinum Equity are among the PE firms investing in the pharma packaging and storage services sector.

Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a home care merger between a company backed by Berkshire Partners and one backed by The Vistria Group.